In a comparative study, excessive PARP activity was found to be a common denominator for photoreceptor cell death in ten different retinal degeneration models, including in the rd1 mouse22 highlighting the potential of PARP inhibitors for the treatment of genetically diverse groups of RP patients. Here, PDE6B is linked to retinitis pigmentosa 1.